Study identifier:D5890C00018
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A follow-up programme for patients using Symbicort SMART in normal clinical practice
Bronchial Asthma
-
No
-
All
5137
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
This patient follow-up programme was designed to describe the extent of Symbicort use in patients prescribed Symbicort as maintenance and reliever therapy in routine clinical practice in comparison with the already documented use of Symbicort as maintenance and reliever therapy in clinical therapies
Location
Location
AARSCHOT, Belgium
Location
ACHEL, Belgium
Location
ALLEUR, Belgium
Location
ALSEMBERG, Belgium
Location
AMAY, Belgium
Location
ANGLEUR, Belgium
Location
ANS, Belgium
Location
ANTHEIT (= WANZE), Belgium
Arms | Assigned Interventions |
---|
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.